Cano Health, Inc. (NYSE:CANO – Get Free Report) saw a significant increase in short interest during the month of September. As of September 15th, there was short interest totalling 32,800,000 shares, an increase of 8.9% from the August 31st total of 30,120,000 shares. Based on an average daily volume of 11,180,000 shares, the short-interest ratio […]
Fusion Pharmaceuticals (NASDAQ:FUSN – Get Free Report) had its target price decreased by equities research analysts at Raymond James from $13.00 to $12.00 in a report issued on Monday, MarketBeat.com reports. The brokerage presently has an “outperform” rating on the stock. Raymond James’ target price would suggest a potential upside of 277.36% from the stock’s […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) saw a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 101,200 shares, a drop of 17.3% from the July 15th total of 122,400 shares. Based on an average daily volume of 51,100 shares, the short-interest ratio […]
Cano Health, Inc. (NYSE:CANO – Get Free Report) was the target of a significant growth in short interest in June. As of June 30th, there was short interest totalling 30,690,000 shares, a growth of 9.0% from the June 15th total of 28,150,000 shares. Approximately 14.7% of the company’s stock are short sold. Based on an […]
Cano Health (NYSE:CANO – Get Rating) had its target price lowered by Citigroup from $5.00 to $4.00 in a report issued on Friday morning, The Fly reports. Cano Health Price Performance NYSE:CANO opened at $1.27 on Friday. Cano Health has a 52 week low of $0.76 and a 52 week high of $9.75. The company […]